Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc.

Biotechnology Research Bothell, Washington, United States 14 employees COCP
Employees
14
Contacts
4
Emails
4
Phones
1

Cocrystal Pharma, Inc. Overview

Headquarters
Bothell, Washington, United States
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
14
Stock Symbol
COCP
Funding
4.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of COVID-19 and other coronaviruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The company is enrolling subjects in a Phase 1 trial with an antiviral candidate for pandemic and seasonal influenza A, and plans to initiate COVID-19 clinical trials in 2022 with an orally administered and inhalation/pulmonary delivered antiviral candidates.

Cocrystal Pharma, Inc. Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
1
25.0% coverage

Cocrystal Pharma, Inc. Org Chart

Sample employees and titles
Name Title Contact
Robert Tomkiewicz Computational Chemistry
Email
Andrew Yeh Scientist
Email
James J. Martin, Cpa Co-ceo & CFO at Cocrystal Pharma, Inc.
Email Phone
Caroline Boucle Lab Technician/administrative Assistant
Email

Employees by Management Level

Executive 3 profiles
Individual contributor 3 profiles
Associate / junior 2 profiles
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 3 3 0
Executive 2 2 2

Cocrystal Pharma, Inc. Tech Stack

Data / AI 2 profiles

Compare Similar Companies to Cocrystal Pharma, Inc.